Search

Your search keyword '"Antinori, S"' showing total 798 results

Search Constraints

Start Over You searched for: Author "Antinori, S" Remove constraint Author: "Antinori, S"
798 results on '"Antinori, S"'

Search Results

1. Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort

2. Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024

3. Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy

5. Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage

6. Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study

7. Charged-particle multiplicity measurement in proton–proton collisions at TeV with ALICE at LHC

8. Charged-particle multiplicity measurement in proton–proton collisions at and 2.36 TeV with ALICE at LHC

9. First proton–proton collisions at the LHC as observed with the ALICE detector: measurement of the charged-particle pseudorapidity density at GeV

10. First proton-proton collisions at the LHC as observed with the ALICE detector: Measurement of the charged-particle pseudorapidity density at √s = 900 GeV

11. Charged-particle multiplicity measurement in proton-proton collisions at √s = 7 TeV with ALICE at LHC

12. Charged-particle multiplicity measurement in proton-proton collisions at √s 0.9 and 2.36 TeV with ALICE at LHC

13. Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV

15. What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres

16. Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV

18. High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial

19. Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV.

20. 1712P Safety and efficacy of influenza and pneumococcal vaccines in cancer patients on active therapy: A prospective study

21. Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study

23. Production of pions, kaons and protons in pp collisions at $\sqrt{s}= 900~\mathrm{GeV}$ with ALICE at the LHC

24. Charged-particle multiplicity measurement in proton–proton collisions at $\sqrt{s}=7$ TeV with ALICE at LHC

25. Charged-particle multiplicity measurement in proton–proton collisions at $\sqrt{s}=0.9$ and 2.36 TeV with ALICE at LHC

26. First proton–proton collisions at the LHC as observed with the ALICE detector: measurement of the charged-particle pseudorapidity density at $\sqrt{s}=900$  GeV

27. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

28. Production and assembly of the ALICE silicon drift detectors

29. The ALICE silicon drift detectors: Production and assembly

30. Design and construction of an end-ladder prototype board with a 2-D HW compressor

36. Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage

40. Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis

Catalog

Books, media, physical & digital resources